These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 27765815)

  • 1. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
    Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
    J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARβ/δ modulates ethanol-induced hepatic effects by decreasing pyridoxal kinase activity.
    Goudarzi M; Koga T; Khozoie C; Mak TD; Kang BH; Fornace AJ; Peters JM
    Toxicology; 2013 Sep; 311(3):87-98. PubMed ID: 23851158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Kinase N Family Negatively Regulates Constitutive Androstane Receptor-Mediated Transcriptional Induction of Cytochrome P450 2b10 in the Livers of Mice.
    Kawase A; Mukai H; Tateishi S; Kuroda S; Kazaoka A; Satoh R; Shimada H; Sugiura R; Iwaki M
    J Pharmacol Exp Ther; 2021 Oct; 379(1):53-63. PubMed ID: 34312179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive androstane receptor (CAR) mediates dieldrin-induced liver tumorigenesis in mouse.
    Wang Z; Wu Q; Li X; Klaunig JE
    Arch Toxicol; 2020 Aug; 94(8):2873-2884. PubMed ID: 32435917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
    Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
    Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver.
    Guo D; Sarkar J; Suino-Powell K; Xu Y; Matsumoto K; Jia Y; Yu S; Khare S; Haldar K; Rao MS; Foreman JE; Monga SP; Peters JM; Xu HE; Reddy JK
    J Biol Chem; 2007 Dec; 282(50):36766-76. PubMed ID: 17962186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease.
    Zarei M; Barroso E; Palomer X; Dai J; Rada P; Quesada-López T; Escolà-Gil JC; Cedó L; Zali MR; Molaei M; Dabiri R; Vázquez S; Pujol E; Valverde ÁM; Villarroya F; Liu Y; Wahli W; Vázquez-Carrera M
    Mol Metab; 2018 Feb; 8():117-131. PubMed ID: 29289645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.
    Fisher CD; Jackson JP; Lickteig AJ; Augustine LM; Cherrington NJ
    Arch Toxicol; 2008 Dec; 82(12):959-64. PubMed ID: 18488193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors.
    Cheng X; Klaassen CD
    Toxicol Sci; 2008 Nov; 106(1):29-36. PubMed ID: 18648086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.
    Khozoie C; Borland MG; Zhu B; Baek S; John S; Hager GL; Shah YM; Gonzalez FJ; Peters JM
    BMC Genomics; 2012 Nov; 13():665. PubMed ID: 23176727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-β/δ modulates mast cell phenotype.
    Yao PL; Morales JL; Gonzalez FJ; Peters JM
    Immunology; 2017 Apr; 150(4):456-467. PubMed ID: 27935639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
    Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
    Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
    Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.
    Borland MG; Krishnan P; Lee C; Albrecht PP; Shan W; Bility MT; Marcus CB; Lin JM; Amin S; Gonzalez FJ; Perdew GH; Peters JM
    Carcinogenesis; 2014 Jul; 35(7):1602-12. PubMed ID: 24639079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring Cyp2b10 mRNA expression at cessation of 2-year carcinogenesis bioassay in mouse liver provides evidence for a carcinogenic mechanism devoid of human relevance: the dalcetrapib experience.
    Hoflack JC; Mueller L; Fowler S; Braendli-Baiocco A; Flint N; Kuhlmann O; Singer T; Roth A
    Toxicol Appl Pharmacol; 2012 Mar; 259(3):355-65. PubMed ID: 22293087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes.
    Zarei M; Barroso E; Palomer X; Escolà-Gil JC; Cedó L; Wahli W; Vázquez-Carrera M
    Clin Investig Arterioscler; 2019; 31(3):111-118. PubMed ID: 30987865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
    Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
    Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury.
    Qian B; Wang C; Li X; Ma P; Dong L; Shen B; Wu H; Li N; Kang K; Ma Y
    Liver Int; 2023 Dec; 43(12):2808-2823. PubMed ID: 37833850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.